Fig. 2From: NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxelAnalysis of chromatin immunoprecipitation sequencing (ChIP-seq) of NFATc2 binding sites. a The number of aligned reads and the number of identified peaks in vehicle group/day 10 and paclitaxel group/day 10. b Schematic diagram illustrated binding site locations. c The genomic distribution (%) of the NFATc2 binding sites in vehicle group/day 10 and paclitaxel group/day 10. d Line chart showing the binding intensity of NFATc2 around the TSS of target genesBack to article page